Scinovex
article Open AccessTop 1% cited

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

Kidney International · 2011 · Vol. 79(12) · pp. 1370–1378
Tamara Isakovaon behalf of the Chronic Renal Insufficiency Cohort (CRIC) Study GroupPatricia WahlGabriela VargasOrlando M. GutiérrezJulia J. SciallaHuiliang XieDina ApplebyLisa NesselKeith BellovichJing ChenL. Lee HammCrystal A. GadegbekuEdward HorwitzRaymond R. TownsendCheryl A.M. AndersonJames P. LashChi‐yuan HsuMary B. LeonardMyles Wolf
Parathyroid Disorders and TreatmentsBiomedical Research and PathophysiologyGenetic Syndromes and ImprintingFibroblast growth factor 23Parathyroid hormoneKidney diseaseMedicineInternal medicineEndocrinologyFibroblast growth factorCalciumReceptor

MeSH terms

Fibroblast Growth Factor-23AgedFemaleFibroblast Growth FactorsGlomerular Filtration RateHumansHyperparathyroidism, SecondaryMaleMiddle AgedParathyroid HormonePhosphatesPredictive Value of TestsProspective StudiesSeverity of Illness IndexTime Factors

Funding

  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases
Citations
1,223
FWCI
42.71
field-weighted impact
References
51
Percentile
100%
vs. same field & year
Citations per year
Cited by
FGF23 induces left ventricular hypertrophy
Journal of Clinical Investigation · 2011 · 1,972 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease · Scinovex